Interpace Biosciences, Inc. (IDXG) — 10-Q Filings
All 10-Q filings from Interpace Biosciences, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Interpace Biosciences' Revenue Plummets 14.5% Amid PancraGEN Coverage Loss
— Nov 12, 2025 Risk: high
Interpace Biosciences, Inc. (IDXG) reported a significant decline in revenue and net income for the nine months ended September 30, 2025, with net revenue falli -
Interpace Biosciences Narrows Q2 Loss to $1.2M
— Aug 7, 2025 Risk: medium
INTERPACE BIOSCIENCES, INC. (IDXG) reported a net loss of $1.2 million for the three months ended June 30, 2025, a significant improvement from the $2.5 million -
Interpace Biosciences Files Q1 2025 10-Q
— May 8, 2025 Risk: low
Interpace Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including balance sheet data for comm -
INTERPACE BIOSCIENCES, INC. Files Q3 2024 Report
— Nov 8, 2024 Risk: low
INTERPACE BIOSCIENCES, INC. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Interpace Diagnostics Group, Inc -
INTERPACE BIOSCIENCES, INC. Files 10-Q for Q2 2024
— Aug 8, 2024 Risk: low
INTERPACE BIOSCIENCES, INC. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Interpace Diagnostics Group, Inc., is incorporate -
INTERPACE BIOSCIENCES, INC. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
INTERPACE BIOSCIENCES, INC. (IDXG) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. INTERPACE BIOSCIENCES, INC. filed a 10-Q for the period ending M
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX